Skip to main content
Back to Novo Holdings

Novo Holdings's Health Care Portfolio

Browse 43 Health Care companies funded by Novo Holdings. See funding amounts, founder contacts, and investment details.

Health Care Companies
43
Total Funding in Health Care
$3.8B

Health Care Portfolio Companies (43)

Export
Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalOncologyPrecision Medicine

Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.

Chicago, United States
May 2026
Post-IPO Debt

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

Foster City, United States
May 2026
Post-IPO Debt

Founder Contacts

19,000+ verified contacts

Health CareHospitalMedical

Route 92 Medical is a medical device company developing a catheter to treat stroke.

San Mateo, United States
April 2026
$50.0M
Private Equity

Founder Contacts

19,000+ verified contacts

AnalyticsBiopharmaBiotechnologyHealth CareLife ScienceMedical DevicePharmaceutical

CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.

Heverlee, Belgium
April 2026
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

San Diego, United States
April 2026
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

South San Francisco, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Copenhagen, Denmark
April 2026
$135.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.

San Francisco, United States
October 2025
$165.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareManufacturingMedicalMedical Device

Nalu Medical is a medical technology company that offers neurostimulation system designed to treat chronic nerve pain.

Carlsbad, United States
September 2025
$50.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.

Schlieren, Switzerland
May 2025
$130.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

HepaRegeniX is developing drugs for treating acute and chronic liver diseases.

Ulm, Germany
April 2025
$24.3M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).

Seattle, United States
March 2025
$187.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Wadenswil, Switzerland
January 2025
$54.9M
Series C

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceuticalTherapeutics

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

Frederiksberg, Denmark
January 2025
$93.2M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

Redwood City, United States
December 2024
$161.0M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.

Risskov, Denmark
July 2024
$13.2M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

San Mateo, United States
May 2024
$182.0M
Series C

Founder Contacts

19,000+ verified contacts

Health CareMental HealthPersonal HealthWellness

Octave provides mental health care that's both accessible to people and sustainable for providers.

San Francisco, United States
February 2024
$5.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.

Copenhagen, Denmark
December 2023
$24.8M
Series A

Founder Contacts

19,000+ verified contacts

Health CareHospitalInformation TechnologyTelehealthUnified Communications

Doctor Anywhere is a telehealth company .

Singapore, Singapore
December 2023
$40.8M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalWellness

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Hellerup, Denmark
October 2023
$57.4M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Health CareHealth InsuranceInsurance

Clever Care Health Plan is a healthcare company that offers medicare advantage health plans to its members.

Huntington Beach, United States
March 2023
$42.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

Alderley Park, United Kingdom
February 2026
$8.1M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Bactolife is a biotechnology company that develops biological solutions to support gut health.

Lyngby, Denmark
January 2026
$35.2M
Series B

Founder Contacts

19,000+ verified contacts

Alternative MedicineBiotechnologyHealth CareMedicalPrecision Medicine

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Cambridge, United States
January 2026
$575.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

GeneticsHealth CareMedical

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

Copenhagen, Denmark
December 2025
$109.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Waltham, United States
November 2025
$200.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsNeuroscience

Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.

Cleveland, United States
October 2025
$14.4M
Undisclosed

Founder Contacts

19,000+ verified contacts

BiopharmaHealth CareMedicalTherapeutics

Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.

San Diego, United States
September 2025
$205.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyDiabetesHealth Care

KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).

Cambridge, United States
September 2025
$125.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

BioinformaticsBiotechnologyGeneticsHealth CareOncology

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

San Francisco, United States
August 2025
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical

MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.

Bangalore, India
July 2025
$47.5M
Series E

Founder Contacts

19,000+ verified contacts

Health Care

Based on our deep science and focused on patients in need.

Watertown, United States
June 2025
$40.0M
Grant

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical Device

Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions.

Los Gatos, United States
March 2025
$120.0M
Series E

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.

Boston, United States
March 2025
$67.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars.

Jersey City, United States
March 2025
$5.6M
Debt Financing

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

Dublin, Ireland
January 2025
$120.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Plymouth Meeting, United States
October 2024
$248.0M
Post Ipo Secondary

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareOncology

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

San Francisco, United States
October 2024
$92.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical Device

Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

Kadima, Israel
July 2024
$105.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.

Oxford, United Kingdom
December 2023
$2.3M
Grant

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Redwood City, United States
November 2023
$200.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore Novo Holdings's Full Portfolio

View all companies funded by Novo Holdings across every industry and funding stage.

View Full Novo Holdings Portfolio